Pharmaceutical Preparations · NV · CIK 1124524
Cryoport provides integrated, temperature-controlled supply chain solutions for life sciences, focusing on cell and gene therapies
Comparable business profile · signals at a glance
In the 90 days to Mar 23, 2026: 4 sold $471K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2026 | Shelton JerrellPresident, CEO | Sell | 2,894 | $8.18 | $24K |
| Mar 23, 2026 | Sawicki Mark WChief Scientific Officer | Sell | 1,341 | $8.18 | $11K |
| Mar 23, 2026 | Stefanovich RobertChief Financial Officer | Sell | 1,094 | $8.18 | $9K |
| Mar 16, 2026 | Shelton JerrellPresident, CEO | Sell | 7,918 | $8.00 | $63K |
| Mar 16, 2026 | Sawicki Mark WChief Scientific Officer | Sell | 3,235 | $8.00 | $26K |
| Mar 16, 2026 | Stefanovich RobertChief Financial Officer | Sell | 2,743 | $8.00 | $22K |
| Mar 16, 2026 | Zecchini Edward JSee Remarks | Sell | 2,014 | $8.00 | $16K |
| Mar 12, 2026 | Stefanovich RobertChief Financial Officer | Sell | 38,700 | $7.76 | $300K |
| Dec 10, 2025 | Mandalam RamkumarDirector | Sell | 11,570 | $9.99 | $116K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.